On the relationship between visual acuity and central retinal (macular) thickness after interventions for macular oedema in diabetics: a review

Anna Bong, Michael Doughty, Norman Button, David Mansfield

Research output: Contribution to journalArticlepeer-review

Abstract

The aim was to compare efficacy of treatments for diabetic macular oedema (DMO) from changes in visual acuity (VA) and central macular thickness (CMT). Peer-reviewed articles from 2004 to 2014 reporting intravitreal injections of bevacizumab (IVB), ranibizumab (IVR) or triamcinolone acetonide (IVTA) or laser photocoagulation therapy (LPT) provided data on pre-treatment (baseline) and final outcome measures. Net changes and relative changes (percentage) were assessed by linear regression analyses.
Original languageEnglish
Pages (from-to)491-497
Number of pages7
JournalClinical and Experimental Optometry
Volume99
Issue number6
Early online date19 Jun 2016
DOIs
Publication statusPublished - Nov 2016

Keywords

  • anti-VEGF treatments, corticosteroid treatments, diabetic macular oedema, laser photocoagulation

Fingerprint Dive into the research topics of 'On the relationship between visual acuity and central retinal (macular) thickness after interventions for macular oedema in diabetics: a review'. Together they form a unique fingerprint.

Cite this